These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9065595

  • 1. Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: 31P and 13C nuclear magnetic resonance studies.
    Vivi A, Tassini M, Ben-Horin H, Navon G, Kaplan O.
    Breast Cancer Res Treat; 1997 Mar; 43(1):15-25. PubMed ID: 9065595
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies.
    Ben-Horin H, Tassini M, Vivi A, Navon G, Kaplan O.
    Cancer Res; 1995 Jul 01; 55(13):2814-21. PubMed ID: 7796408
    [Abstract] [Full Text] [Related]

  • 3. Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.
    Kaplan O, Navon G, Lyon RC, Faustino PJ, Straka EJ, Cohen JS.
    Cancer Res; 1990 Feb 01; 50(3):544-51. PubMed ID: 2297696
    [Abstract] [Full Text] [Related]

  • 4. Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy.
    Mardor Y, Kaplan O, Sterin M, Ruiz-Cabello J, Ash E, Roth Y, Ringel I, Cohen JS.
    Cancer Res; 2000 Sep 15; 60(18):5179-86. PubMed ID: 11016646
    [Abstract] [Full Text] [Related]

  • 5. Adriamycin resistance modulation induced by lonidamine in human breast cancer cells.
    Zupi G, Molinari A, D'Agnano I, Meschini S, Del Bufalo D, Matarrese P, Candiloro A, Calcabrini A, Citro G, Arancia G.
    Anticancer Res; 1995 Sep 15; 15(6B):2469-77. PubMed ID: 8669810
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification.
    Ben-Yoseph O, Lyons JC, Song CW, Ross BD.
    J Neurooncol; 1998 Jan 15; 36(2):149-57. PubMed ID: 9525814
    [Abstract] [Full Text] [Related]

  • 7. bcl-2 inhibits mitochondrial metabolism and lonidamine-induced apoptosis in adriamycin-resistant MCF7 cells.
    Biroccio A, Del Bufalo D, Fanciulli M, Bruno T, Zupi G, Floridi A.
    Int J Cancer; 1999 Jul 02; 82(1):125-30. PubMed ID: 10360831
    [Abstract] [Full Text] [Related]

  • 8. Effects of hyperglycemia on lonidamine-induced acidification and de-energization of human melanoma xenografts and sensitization to melphalan.
    Nath K, Nelson DS, Heitjan DF, Zhou R, Leeper DB, Glickson JD.
    NMR Biomed; 2015 Mar 02; 28(3):395-403. PubMed ID: 25702942
    [Abstract] [Full Text] [Related]

  • 9. Imaging chemical exchange saturation transfer (CEST) effects following tumor-selective acidification using lonidamine.
    McVicar N, Li AX, Meakin SO, Bartha R.
    NMR Biomed; 2015 May 02; 28(5):566-75. PubMed ID: 25808190
    [Abstract] [Full Text] [Related]

  • 10. Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine.
    Fanciulli M, Bruno T, Giovannelli A, Gentile FP, Di Padova M, Rubiu O, Floridi A.
    Clin Cancer Res; 2000 Apr 02; 6(4):1590-7. PubMed ID: 10778993
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of antineoplastic activity of lonidamine.
    Nath K, Guo L, Nancolas B, Nelson DS, Shestov AA, Lee SC, Roman J, Zhou R, Leeper DB, Halestrap AP, Blair IA, Glickson JD.
    Biochim Biophys Acta; 2016 Dec 02; 1866(2):151-162. PubMed ID: 27497601
    [Abstract] [Full Text] [Related]

  • 12. Effect of the antitumor drug lonidamine on glucose metabolism of adriamycin-sensitive and -resistant human breast cancer cells.
    Fanciulli M, Valentini A, Bruno T, Citro G, Zupi G, Floridi A.
    Oncol Res; 1996 Dec 02; 8(3):111-20. PubMed ID: 8823807
    [Abstract] [Full Text] [Related]

  • 13. In vitro potentiation by lonidamine of the cytotoxic effect of adriamycin on primary and established breast cancer cell lines.
    Savini S, Zoli W, Nanni O, Volpi A, Frassineti GL, Magni E, Flamigni A, Amadori A, Amadori D.
    Breast Cancer Res Treat; 1992 Dec 02; 24(1):27-34. PubMed ID: 1463869
    [Abstract] [Full Text] [Related]

  • 14. Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15.
    Ballaré C, Portela P, Schiaffi J, Yomha R, Mordoh J.
    Breast Cancer Res Treat; 1998 Jan 02; 47(2):163-70. PubMed ID: 9497104
    [Abstract] [Full Text] [Related]

  • 15. The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters.
    Nancolas B, Guo L, Zhou R, Nath K, Nelson DS, Leeper DB, Blair IA, Glickson JD, Halestrap AP.
    Biochem J; 2016 Apr 01; 473(7):929-36. PubMed ID: 26831515
    [Abstract] [Full Text] [Related]

  • 16. Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies.
    Jaroszewski JW, Kaplan O, Cohen JS.
    Cancer Res; 1990 Nov 01; 50(21):6936-43. PubMed ID: 2208159
    [Abstract] [Full Text] [Related]

  • 17. Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy.
    Lyon RC, Cohen JS, Faustino PJ, Megnin F, Myers CE.
    Cancer Res; 1988 Feb 15; 48(4):870-7. PubMed ID: 3338082
    [Abstract] [Full Text] [Related]

  • 18. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C, Guan X, Xue H, Wang P, Wang M, Gai X.
    Pathol Res Pract; 2017 Jul 15; 213(7):848-853. PubMed ID: 28554760
    [Abstract] [Full Text] [Related]

  • 19. The multidrug resistance phenotype: 31P nuclear magnetic resonance characterization and 2-deoxyglucose toxicity.
    Kaplan O, Jaroszewski JW, Clarke R, Fairchild CR, Schoenlein P, Goldenberg S, Gottesman MM, Cohen JS.
    Cancer Res; 1991 Mar 15; 51(6):1638-44. PubMed ID: 1998955
    [Abstract] [Full Text] [Related]

  • 20. Chemotherapy-induced changes in the energetics of human breast cancer cells; 31P- and 13C-NMR studies.
    Neeman M, Eldar H, Rushkin E, Degani H.
    Biochim Biophys Acta; 1990 May 02; 1052(2):255-63. PubMed ID: 2334736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.